Galmed Pharmaceuticals Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$0.55

-0.02 (-3.14%)

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +3,019.3% upside

Low Target $9.83

Average Target $17.25

High Target $23.67

Current Price $0.55

Current
$0.55

Target
$17.25

$9.83 $17.25 avg $23.67

Scenario Analysis

Bear Case

$9.83

1,677.6%

Low target

Base Case

$17.25

+3,019.3%

Avg target

Bull Case

$23.67

+4,180.3%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$2.34

-76.4% from high

52-Week Low

$0.41

+34.5% from low

Target vs 52W High

$17.25

+637.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.2%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.6%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-40.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.0%